Subject of the day
HSIC
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
FY 2010–2025 · 16 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $13.18B | +13.8% | |
| Gross profit | $3.86B | +4.8% | |
| Operating income | $621.00M | +2.0% | |
| Net income | $398.00M | +13.3% | |
| Cash from ops | $500.00M | +2.1% |
$90.12
▼ -0.62 (-0.7%)
| 52w hi | $90.74 |
|---|---|
| 52w lo | $62.03 |
| Vol | 927.65K |
| As of | Aug 13 |
Our score +0.49
| Short | +0.38 |
|---|---|
| Medium | +0.62 |
| Long | +0.43 |
computed 2026-08-13
Henry Schein, Inc.
Healthcare · Medical Distribution
| Market cap | $10.27B |
|---|---|
| Enterprise value | $15.33B |
| Trailing P/E | 26.27x |
| Forward P/E | 15.02x |
| EV / EBITDA | 14.20x |
| P / S (ttm) | 0.74x |
| Profit margin | 3.0% |
| Return on equity | 8.9% |
| Revenue growth | +6.7% |
| Earnings growth | +17.1% |
| Debt / equity | 80.73 |
| Beta vs SPX | 0.57 |
|---|---|
| Corr SPX | 0.34 |
| Annual vol | 27.2% |
| Annual ret | +17.6% |
| Sharpe | 0.65 |
| Max DD | -24.3% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.22 | |
| Sector | +0.12 | |
| Technical | +0.30 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $90.93 | $91.54 | $89.10 | $90.12 | 927.65K |
| Aug 12 | $88.95 | $90.93 | $88.47 | $90.74 | 1.04M |
| Aug 11 | $88.00 | $90.08 | $88.00 | $89.18 | 927.80K |
| Aug 10 | $87.57 | $88.37 | $87.47 | $88.08 | 1.40M |
| Aug 7 | $88.12 | $88.83 | $87.57 | $88.13 | 649.70K |